In 2012, Edwards Lifesciences acquired BMEYE to advance the Nexfin technology into the ClearSight system, the next generation in noninvasive hemodynamic monitoring for continuous decision support.
Please update your browser
Please update to a current version of your preferred browser, this site will perform effectively on the following:
Unable to update your browser?If you are on a computer, that is maintained by an admin and you cannot install a new browser, ask your admin about it. If you can't change your browser because of compatibility issues, think about installing a second browser for browsing and keep this old one for compatibility